Immunohistochemical markers as predictive tools for breast cancer

Area of Science:

• Oncology
• Pathology
• Biomarker Analysis

Background:

• Predictive markers are crucial for guiding breast cancer treatment decisions.
• Steroid receptors have long been utilized as clinical predictive markers.
• Immunohistochemistry is the primary assay for assessing these markers.

Purpose of the Study:

• To highlight the importance of accurate interpretation of predictive markers in breast cancer.
• To emphasize the clinical significance of understanding technical pitfalls in marker assays.
• To underscore the role of oestrogen receptor as a reliable predictive marker.

Main Methods:

• Review of current practices in predictive marker assessment for breast cancer.
• Discussion of immunohistochemistry as the predominant assay methodology.
• Analysis of challenges including tissue fixation, methodology, interpretation, and quantification.

Main Results:

• Oestrogen receptor remains the most reliable predictive marker for treatment response in breast cancer.
• Despite extensive use, immunohistochemistry faces challenges impacting result accuracy.
• Understanding marker expression in relation to breast cancer pathology is critical.

Conclusions:

• Accurate interpretation of predictive markers is essential for appropriate patient management.
• Awareness of technical limitations in assays like immunohistochemistry is crucial.
• False negative or positive results can significantly affect breast cancer treatment strategies.